AstraZeneca Completes Divestment Of Rights To Crestor In Europe To Grünenthal

(RTTNews) – AstraZeneca plc (AZN.L, AZN), on Wednesday, said it completed the divestment of the rights to Crestor (rosuvastatin) and associated medicines in over 30 countries in Europe to Grünenthal GmbH (Grünenthal). Rights in the UK and Spain were not included in theRead MoreMarketsMarkets Feed